Patents Assigned to AxImmune, Inc.
  • Beta-alethine, immune modulators, and uses thereof
    Patent number: 11672771
    Abstract: The present disclosure provides methods, kits, and compositions comprising ?-alethine and one or more immune modulators and methods to determine when they are advantageous. Particular applications include the use of ?-alethine and one or more immune modulators in the treatment of cancer.
    Type: Grant
    Filed: November 3, 2017
    Date of Patent: June 13, 2023
    Assignees: AxImmune, Inc., Colorado State University Research Foundation
    Inventors: Floyd Taub, Amanda Guth